AU6462598A - Methods and compositions for treating polycystic ovary syndrome - Google Patents
Methods and compositions for treating polycystic ovary syndromeInfo
- Publication number
- AU6462598A AU6462598A AU64625/98A AU6462598A AU6462598A AU 6462598 A AU6462598 A AU 6462598A AU 64625/98 A AU64625/98 A AU 64625/98A AU 6462598 A AU6462598 A AU 6462598A AU 6462598 A AU6462598 A AU 6462598A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- polycystic ovary
- ovary syndrome
- treating polycystic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4115297P | 1997-03-17 | 1997-03-17 | |
US60041152 | 1997-03-17 | ||
GB9800215 | 1998-01-06 | ||
GBGB9800215.7A GB9800215D0 (en) | 1998-01-06 | 1998-01-06 | Methods and compositions for treating polycystic ovary syndrome |
PCT/US1998/004955 WO1998041211A1 (en) | 1997-03-17 | 1998-03-13 | Methods and compositions for treating polycystic ovary syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6462598A true AU6462598A (en) | 1998-10-12 |
Family
ID=26312894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64625/98A Abandoned AU6462598A (en) | 1997-03-17 | 1998-03-13 | Methods and compositions for treating polycystic ovary syndrome |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6462598A (en) |
WO (1) | WO1998041211A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU94046044A (en) * | 1992-05-20 | 1996-10-10 | Мерк Энд Ко. | NEW 7β-SUBSTITUTED 4-AZA-5a-CHOLESTAN-ONES AS INHIBITORS OF 5a-REDUCTASE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF ITS PREPARING |
US5237064A (en) * | 1992-05-20 | 1993-08-17 | Merck & Co., Inc. | Process for producing 7β-substituted-aza-5αandrostan-3-ones |
US5512555A (en) * | 1994-07-21 | 1996-04-30 | Merck & Co., Inc. | Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one |
US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
-
1998
- 1998-03-13 AU AU64625/98A patent/AU6462598A/en not_active Abandoned
- 1998-03-13 WO PCT/US1998/004955 patent/WO1998041211A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998041211A1 (en) | 1998-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1296099A (en) | Methods and compositions for treating dermatoses | |
AU1694497A (en) | Disinfecting compositions and processes for disinfecting surfaces | |
AU4063397A (en) | Method and composition for treating substrates for wettability | |
AU2593900A (en) | Composition and method for treating glaucoma | |
AU8693098A (en) | Compositions and methods for treating diabetes | |
AU3897597A (en) | Catalyst composition and method for its manufacturing | |
IL132435A (en) | Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same | |
AU7564694A (en) | Erection-inducing methods and compositions | |
AU7323294A (en) | Perfluoroelastomeric compositions and methods | |
AU4813197A (en) | Compositions and methods for treating viral infections | |
AU7212996A (en) | Compositions and methods for controlling harmful fungi | |
AU1278899A (en) | Compositions and processes for drying substrates | |
AU7572994A (en) | Inorganic hardening composition | |
AUPO976797A0 (en) | Method and composition (III) | |
AU8019598A (en) | Composition and method for providing glutamine | |
AU6986696A (en) | Compositions and methods for controlling harmful fungi | |
AUPO976597A0 (en) | Method and composition (I) | |
AU2767597A (en) | Compositions and methods for controlling harmful fungi | |
AU5798996A (en) | Adnaz, compositions and processes | |
AU6368394A (en) | Polymer-polypeptide composition and method | |
AU9592698A (en) | Methods and compositions for treating rheumatoid arthritis | |
AU3910197A (en) | Composition for treating periodontitis | |
AU7364598A (en) | Coating composition and method | |
AU7675198A (en) | Sucralfate-containing composition and process for the preparation thereof | |
AU8019798A (en) | Method and compositions for treating hyperlipidemia and other conditions |